Smoking cessation for substance abuse inpatients

Area of Science:

• Addiction Medicine
• Behavioral Health
• Public Health

Background:

• Smoking is prevalent among individuals with substance use disorders.
• Smoking cessation interventions are crucial for improving overall health outcomes in this population.
• Understanding the impact of smoking cessation on substance abuse treatment is essential.

Purpose of the Study:

• To investigate the effects of a smoking cessation program on substance abuse inpatients.
• To assess the impact on continued inpatient treatment, nicotine reduction, and postdischarge outcomes.
• To determine if smoking cessation negatively affects substance use or hospital readmission rates.

Main Methods:

• A randomized controlled trial involving 39 male veterans with substance abuse disorders.
• Participants were assigned to either a stop-smoking group (n=19) or a wait-list control group (n=20).
• Follow-up assessments were conducted at 3 and 6 months postdischarge, evaluating treatment continuation, nicotine delivery, substance use, and readmission rates.

Main Results:

• Stop-smoking participants were more likely to continue inpatient treatment for at least 30 days postenrollment.
• Participants in the stop-smoking program reported greater reductions in cigarette nicotine delivery.
• No adverse effects on postdischarge substance use or hospital readmission rates were observed for the stop-smoking group.

Conclusions:

• Smoking cessation programs can be safely integrated into substance abuse treatment for male veterans.
• These programs may enhance treatment engagement and reduce nicotine dependence without compromising recovery.
• Further research should explore long-term benefits and broader implementation strategies.